{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-26-005379","form_type":"8-K","ticker":"WT","cik":"0000880631","company_name":"WisdomTree, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.856485+00:00","generated_at":"2026-05-15T00:28:44.008358+00:00","sec_items":["1.01","2.01","2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"WisdomTree Q1 GAAP net loss $23.1M; adjusted EPS $0.27; AUM record $152.6B; completes Atlantic House buy","bullets":["Net loss $23.1M ($0.17 diluted loss); adjusted net income $40.6M ($0.27 adjusted EPS).","Revenue $159.5M, up 47.5% YoY; AUM record $152.6B; net inflows $5.9B.","Operating margin 37.2% (39.3% adjusted), up 560 bps YoY; gross margin 84.4%.","Closed acquisition of Atlantic House for £150M (~$200M) cash; adds defined outcome capabilities.","Declared $0.03 quarterly dividend, payable May 27; record May 13."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-26-005379","json":"https://secwatch.observer/filing/0001214659-26-005379.json","markdown":"https://secwatch.observer/filing/0001214659-26-005379.md","text":"https://secwatch.observer/filing/0001214659-26-005379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/d4292638k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:28:44.008358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"062bf9b6b96ca15047345bb1f5d3fb334324ece4","claim":"WisdomTree, Inc. reported first quarter of 2026 results: revenue $159.5 million, net income ($23.1) million, EPS ($0.17).","evidence_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the prior quarter. 0.42% revenue yield (2) , unchanged from the prior quarter. $159.5 million of operating revenues , an increase of 8.2% from the prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","confidence":0.9},{"claim_id":"64430256eabcbdd1c9f5ef8d883ed1c0b0d9cc97","claim":"WisdomTree, Inc. completed an acquisition involving Atlantic House Holdings Limited for £150.0 million (approximately $200.0 million) in cash (closed 2026-05-01).","evidence_excerpt":"On May 1, 2026, the Buyer completed the Acquisition for a purchase price of £150.0 million (approximately $200.0 million) in cash paid at the closing, subject to customary post-closing adjustments, including adjustments to cash, indebtedness and working capital.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","confidence":0.9},{"claim_id":"23ee65e519f8df2cf1992153484179ea1592a82c","claim":"WisdomTree, Inc. entered into Purchase Agreement with Atlantic House Holdings Limited valued at £150.0 million (approximately $200.0 million) (effective 2026-03-13).","evidence_excerpt":"WisdomTree, Inc. (the “Company”) and WisdomTree International Holdings Ltd (the “Buyer”), a wholly-owned subsidiary of the Company, entered into a Sale and Purchase Agreement (the “Purchase Agreement”) with Atlantic House Holdings Limited, a private limited company incorporated in England and Wales (“Atlantic House”), the shareholders of Atlantic House (together, the “Sellers”), the EBT Trustee and the Individual Guarantor (each as defined in the Purchase Agreement), pursuant to which the Buyer agreed to acquire from the Sellers all of the issued and outstanding share capital of Atlantic House (the “Acquisition”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001645590-26-000052","ticker":"HPE","company_name":"Hewlett Packard Enterprise Co","filed_at":"2026-06-01T20:09:22+00:00","headline":"HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework","event_type":"earnings","sec_items":["1.01","2.02","5.02","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: earnings_release, material_agreement","same SEC item: 1.01, 2.02, 7.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001645590-26-000052","json":"https://secwatch.observer/filing/0001645590-26-000052.json","markdown":"https://secwatch.observer/filing/0001645590-26-000052.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645590/000164559026000052/0001645590-26-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645590/000164559026000052/hpe-20260601.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"gross margin, and non-GAAP diluted net EPS, as well as its highest-ever free cash flow generation for a second quarter. Second Quarter Fiscal 2026 Financial Results • Revenue : $10.7 billion, up 40% from the prior-year period • Gross margins : ◦ GAAP of 36.5%, up 810 basis points from the prior-year period and up 60 basis points sequentially ◦ Non-GAAP (1) of 36.9%,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1645590/000164559026000052/0001645590-26-000052-index.htm"}},{"accession":"0001104659-26-058250","ticker":"FSK","company_name":"FS KKR Capital Corp","filed_at":"2026-05-11T23:59:59+00:00","headline":"FSK posts Q1 GAAP loss of $1.57/sh, NAV falls to $18.83; announces $150M preferred, tender, buyback","event_type":"earnings","sec_items":["1.01","2.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release, material_agreement","same SEC item: 1.01, 2.02, 7.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-058250","json":"https://secwatch.observer/filing/0001104659-26-058250.json","markdown":"https://secwatch.observer/filing/0001104659-26-058250.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422183/000110465926058250/0001104659-26-058250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422183/000110465926058250/tm2614112d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"Earnings (Loss) per share of ($1.57), compared to Earnings (Loss) per share of ($0.41) for the quarter ended December 31, 2025","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1422183/000110465926058250/0001104659-26-058250-index.htm"}},{"accession":"0001656472-26-000032","ticker":"CRON","company_name":"Cronos Group Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9","event_type":"earnings","sec_items":["1.01","2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 1.01, 2.02, 8.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001656472-26-000032","json":"https://secwatch.observer/filing/0001656472-26-000032.json","markdown":"https://secwatch.observer/filing/0001656472-26-000032.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/0001656472-26-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/cron-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"reference in such a filing or document. \n\n--- EX-99.1 (EX-99.1) ---\n\nCronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/0001656472-26-000032-index.htm"}},{"accession":"0001104659-26-058226","ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-05-11T23:59:59+00:00","headline":"Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 7.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-058226","json":"https://secwatch.observer/filing/0001104659-26-058226.json","markdown":"https://secwatch.observer/filing/0001104659-26-058226.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/0001104659-26-058226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/ach-20260511x8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"Commission this morning. ​ Details on First Quarter 2026 Results ​ ​ First Quarter Results (1) ​ ($ in millions, except per share data) ​ ​ ​ 1Q26 ​ ​ ​ 1Q25 Net Revenue ​ $ 627.8 ​ $ 673.9 ​ ​ ​ ​ ​ ​ ​ Loss from continuing operations, net of tax, GAAP ​ $ (6.5) ​ $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP ​ $ (3.1) ​ $ 23.2 ​ ​ ​","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/0001104659-26-058226-index.htm"}},{"accession":"0001104659-26-058234","ticker":"LQDA","company_name":"Liquidia Corp","filed_at":"2026-05-11T23:59:59+00:00","headline":"Liquidia Q1 2026 net income $53M vs $38M loss YoY; YUTREPIA sales $130M","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-058234","json":"https://secwatch.observer/filing/0001104659-26-058234.json","markdown":"https://secwatch.observer/filing/0001104659-26-058234.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926058234/0001104659-26-058234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926058234/tm2614109d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"First Quarter 2026 Financial Results YUTREPIA sales led to the company’s third consecutive quarter of profitability with net income of $52.9 million and positive non-GAAP adjusted EBITDA of $71.2 million in the first quarter of 2026. Cash and cash equivalents totaled $222.8 million as of March 31, 2026, compared to $190.7 million as of December 31, 2025. Product sales, net, were $129.9 million for the three months ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926058234/0001104659-26-058234-index.htm"}},{"accession":"0001193125-26-215661","ticker":"APC","company_name":"ARKO Petroleum Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"ARKO Petroleum Q1 net income $8.1M ($4.5M), Adj. EBITDA $36.4M ($30.9M); completes IPO","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 7.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-215661","json":"https://secwatch.observer/filing/0001193125-26-215661.json","markdown":"https://secwatch.observer/filing/0001193125-26-215661.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2080921/000119312526215661/0001193125-26-215661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2080921/000119312526215661/apc-20260511.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights (vs. Year-Ago Period) 1,2 • Net income for the quarter increased to $8.1 million compared to $4.5 million. • Adjusted EBITDA for the quarter increased to $36.4 million compared to $30.9 million. • Net cash provided by operating activities for the quarter was","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2080921/000119312526215661/0001193125-26-215661-index.htm"}},{"accession":"0001193125-26-215674","ticker":"LXEO","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-215674","json":"https://secwatch.observer/filing/0001193125-26-215674.json","markdown":"https://secwatch.observer/filing/0001193125-26-215674.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/0001193125-26-215674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/lxeo-20260511.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/0001193125-26-215674-index.htm"}},{"accession":"0001493152-26-022090","ticker":"NESR","company_name":"National Energy Services Reunited Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"NESR Q1 revenue $404.6M (+33.5% YoY); net income $23.8M (+129%); EPS $0.23","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 7.01, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-022090","json":"https://secwatch.observer/filing/0001493152-26-022090.json","markdown":"https://secwatch.observer/filing/0001493152-26-022090.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698514/000149315226022090/0001493152-26-022090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698514/000149315226022090/form8-k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"across the United States and Europe. 0.36% average advisory fee , a 1 basis point increase from the\nprior quarter. 0.42% revenue yield (2) , unchanged from the prior\nquarter. $159.5 million of operating revenues , an increase of 8.2% from\nthe prior quarter due to higher average AUM and higher other revenues attributable to our European listed exchange-traded","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/880631/000121465926005379/0001214659-26-005379-index.htm","comparable_excerpt":"National Energy Services Reunited Corp. Reports First Quarter 2026 Financial Results ● Revenue for the quarter ended March 31, 2026, is $404.6 million, reflecting an increase of 33.5% year-over-year and 1.6% sequentially ● Net income for the quarter ended March 31, 2026, is $23.8 million, improving 205.4% sequentially and 129.3% year-over-year ● Diluted Earnings per Share (EPS) for the three months ended March 31, 2026 is $0.23, representing an increase of 109.1% year-over-year and 201.3% sequentially","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1698514/000149315226022090/0001493152-26-022090-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}